Data as of Oct 28, 2026.
FTXH vs IXJ: Differences, Returns & Fees
Over the year to Oct 28, 2026, FTXH returned +47.9% to IXJ's +20.8%; 38% of their weight is in the same names.
askIQ about this page
askIQ about FTXH and IXJ
Net assets on Oct 27, 2026: $1.2bn for First Trust Nasdaq Pharmaceuticals ETF and $4.5bn for iShares Global Healthcare ETF.
Pair scorecard
IXJ costs 0.22 points a year less; their one-year returns differ by 27.1 points; IXJ is 3.8 times larger.
| Measure | FTXH | IXJ |
|---|---|---|
| Return | ||
| Total return, 1 year | +47.9% | +20.8% |
| Benchmark | ||
| What it tracks | Nasdaq US Smart Pharmaceuticals Index | S&P Global 1200 Health Care Index |
| Cost and size | ||
| Expense ratio | 0.60% | 0.38% |
| Net assets, as of Oct 27, 2026 | $1.2bn | $4.5bn |
| Holdings | ||
| Holdings in common | 38% | |
| Top ten holdings, share of the fund | 54.8% | 47.5% |
Holdings in common uses holdings dated Oct 27, 2026. Method
Risk and return
Sep 30, 2016 to Oct 23, 2026 · 525 weekly returnsIXJ returned slightly more: +152.0% to +145.2%. IXJ swung less: 16.4% to 18.3%. IXJ fell less at its worst: −24.3% to −28.9%.
Full scorecard
9 measures, with how each is measured Open ↓
| Measure | FTXH | IXJ | Edge | How it is measured |
|---|---|---|---|---|
| Return | ||||
| Total return | +145.2% | +152.0% | IXJ (slight) | Price change plus distributions, reinvested. |
| Annualized | +9.3% | +9.6% | IXJ (slight) | Total return as a yearly rate. |
| Price return | +116.4% | +117.2% | Tie | Price change alone, distributions left out. |
| Risk | ||||
| Volatility | 18.3% | 16.4% | IXJ | Spread of weekly returns, annualized. Lower is steadier. |
| Downside deviation | 12.8% | 11.5% | IXJ | Like volatility, counting only weeks below the Treasury bill rate. |
| Max drawdown | −28.9% | −24.3% | IXJ | Deepest fall from a high to the low after it. |
| Risk-adjusted | ||||
| Sharpe | 0.44 | 0.49 | IXJ (slight) | Return above Treasury bills per unit of volatility. |
| Sortino | 0.63 | 0.70 | IXJ (slight) | Return above Treasury bills per unit of downside deviation. |
| Calmar | 0.32 | 0.39 | IXJ | Annualized return divided by the max drawdown. |
Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 525 weekly returns. Cash rate: the 13-week Treasury bill.
What they share
By the books each fund has filed, FTXH and IXJ hold 38% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.
half
38% in common
Only in one fund ↓
Side by side
FTXH and IXJ on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.
FTXH and IXJ are built for the same job. How do they differ in cost, holdings and results?
- What each follows. FTXH follows Nasdaq US Smart Pharmaceuticals Index and IXJ follows S&P Global 1200 Health Care Index.
- Holdings in common. 38% of the weight is in the same securities (holdings dated Oct 27, 2026).
- One-year total return. Over 1 year to Oct 28, 2026 FTXH returned +47.9% and IXJ +20.8% with distributions reinvested, a gap of 27.1 points.
Data as of Oct 28, 2026.
The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.
FTXH
FTXH tracks an index. Over the year to Oct 28, 2026 it returned +47.9% with distributions reinvested. The prospectus expense ratio is 0.60% a year. By its holdings published by its issuer for Oct 27, 2026, 68% of the fund by weight is stocks the S&P 500 also holds, across 50 positions, with the top ten at 54.8%.
IXJ
IXJ tracks an index. Over the year to Oct 28, 2026 it returned +20.8% with distributions reinvested. The prospectus expense ratio is 0.38% a year. By its holdings published by its issuer for Oct 27, 2026, 71% of the fund by weight is stocks the S&P 500 also holds, across 110 positions, with the top ten at 47.5%.
Questions people ask
- Which returned more over the last year, FTXH or IXJ?
- In the year to Oct 28, 2026, with distributions reinvested, FTXH returned +47.9% and IXJ +20.8%.
- Which is cheaper, FTXH or IXJ?
- IXJ is cheaper, by 0.22 percentage points a year. That is about $22 on $10,000 held for a year. Fees come from each fund's prospectus.
Links are sources, not endorsements. A comparison is not a recommendation.
How this is computed
Overlap adds up the smaller of the two weights for each security both funds hold.
Cite this pageCitation, APA and Markdown
ETFIQ, FTXH against IXJ, data as of Oct 28, 2026. https://etfiq.com/compare/any/ftxh-vs-ixj
ETFIQ. (Oct 28, 2026). FTXH against IXJ. Retrieved from https://etfiq.com/compare/any/ftxh-vs-ixj
[FTXH against IXJ (ETFIQ, Oct 28, 2026)](https://etfiq.com/compare/any/ftxh-vs-ixj)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.